CPIG
ARKG icon

Chicago Partners Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Chicago Partners Investment Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-400
Closed -$10K – 351
2018
Q3 		$10K Hold
400
– – ﹤0.01% 807
2018
Q2 		$12K Buy
400
+200
+100% +$5.57K ﹤0.01% 761
2018
Q1 		$5K Buy
+200
New +$5.42K ﹤0.01% 840

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Arlington Capital Management Arlington Heights, Illinois $177M AUM 44.15% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $49.2B AUM 14.31% 1-Year Est. Return
SI
Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
SCA
Snowden Capital Advisors New York $3.76B AUM 23.4% 1-Year Est. Return

Chicago Partners Investment Group's ARKG Position: Q4 2018 in Review

Chicago Partners Investment Group sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2018, closing a stake of 400 shares — an estimated $10K sold.

Chicago Partners Investment Group first reported a position in ARKG in Q1 2018 and held it in 3 quarters. The position peaked at $12K in Q2 2018. 58 funds tracked by Wall St. Rank hold ARKG as of Q4 2018.

  • Chicago Partners Investment Group reported no remaining ARK Genomic Revolution ETF position as of Q4 2018 after selling out during the quarter.
  • Chicago Partners Investment Group sold 400 ARK Genomic Revolution ETF shares in Q4 2018, an estimated $10K.
  • Chicago Partners Investment Group first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 3 quarters.
  • Chicago Partners Investment Group's ARK Genomic Revolution ETF position peaked at $12K in Q2 2018.
  • 58 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2018.

Based on Chicago Partners Investment Group's 13F filing for Q4 2018, filed 11 Jan 2019.